Found: 8
Select item for more details and to access through your institution.
Bayesian Model Infers Drug Repurposing Candidates for Treatment of COVID-19.
- Published in:
- Applied Sciences (2076-3417), 2021, v. 11, n. 6, p. 2466, doi. 10.3390/app11062466
- By:
- Publication type:
- Article
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Hypothesis-Agnostic Network-Based Analysis of Real-World Data Suggests Ondansetron is Associated with Lower COVID-19 Any Cause Mortality.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 3, p. 359, doi. 10.1007/s40801-022-00303-9
- By:
- Publication type:
- Article
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94438-4
- By:
- Publication type:
- Article
Elevated levels of mitochondrial CoQ10 induce ROS-mediated apoptosis in pancreatic cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84852-z
- By:
- Publication type:
- Article
Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05152-8
- By:
- Publication type:
- Article
Plasma Metabolite Signature Classifies Male LRRK2 Parkinson's Disease Patients.
- Published in:
- Metabolites (2218-1989), 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/metabo12020149
- By:
- Publication type:
- Article
Identification and validation of N-acetylputrescine in combination with non-canonical clinical features as a Parkinson's disease biomarker panel.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-60872-3
- By:
- Publication type:
- Article